NILOTINIB for Remission not achieved: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where NILOTINIB was used for Remission not achieved.
Most Reported Side Effects for NILOTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,667 | 11.5% | 2,661 | 189 |
| Fatigue | 1,679 | 7.3% | 240 | 380 |
| Rash | 1,250 | 5.4% | 27 | 199 |
| Nausea | 1,180 | 5.1% | 173 | 271 |
| Headache | 1,177 | 5.1% | 208 | 296 |
| Pain | 1,169 | 5.1% | 106 | 270 |
| Dyspnoea | 1,070 | 4.6% | 339 | 402 |
| Diarrhoea | 998 | 4.3% | 245 | 238 |
| Drug ineffective | 992 | 4.3% | 99 | 169 |
| Malaise | 961 | 4.2% | 239 | 290 |
| Arthralgia | 925 | 4.0% | 223 | 168 |
| Pyrexia | 909 | 3.9% | 284 | 372 |
| Pruritus | 900 | 3.9% | 205 | 145 |
| Asthenia | 853 | 3.7% | 273 | 272 |
| Vomiting | 830 | 3.6% | 208 | 291 |
Other Indications for NILOTINIB
Chronic myeloid leukaemia (14,842)
Product used for unknown indication (5,339)
Acute lymphocytic leukaemia (419)
Philadelphia positive chronic myeloid leukaemia (364)
Leukaemia (203)
Philadelphia chromosome positive (153)
Myeloid leukaemia (105)
Gastrointestinal stromal tumour (104)
Neoplasm malignant (63)
Acute myeloid leukaemia (59)